Bovine Vaccines - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509240615

Publication Date:

September 24, 2024

Pages:

152

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Vaccines for Bovine
The global market for Bovine Vaccines was estimated to be worth US$ 1534 million in 2023 and is forecast to a readjusted size of US$ 2435.2 million by 2030 with a CAGR of 6.8% during the forecast period 2024-2030
The bovine vaccines market is experiencing steady growth due to the increasing demand for livestock products and the rising prevalence of bovine diseases. Bovine vaccines play a crucial role in preventing and controlling viral, bacterial, and parasitic diseases in cattle. The market is driven by factors such as the growth of the dairy and meat industries, the need to ensure animal health and welfare, and the implementation of stringent disease control measures. Advancements in vaccine technology, including the development of more effective and safer vaccines, are further contributing to market growth. However, challenges such as vaccine storage and transportation requirements, the presence of counterfeit vaccines, and the high costs associated with vaccine procurement and administration may hinder market expansion. With the continuous focus on disease prevention, biosecurity practices, and sustainable livestock production, the bovine vaccines market is expected to witness sustained growth in the coming years.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bovine Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bovine Vaccines by region & country, by Type, and by Application.
The Bovine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bovine Vaccines.
麻豆原创 Segmentation
By Company
Jinyu Group
Cavet Bio
CAHIC
Tecon Group
Shen Lian
Biogenesis Bag贸
BIGVET Biotech
Indian Immunologicals
Boehringer Ingelheim
MSD Animal Health
CEVA
Bayer HealthCare
VECOL
Boehringer Ingelheim
Brilliant Bio Pharma
VETAL
BVI
LIMOR
ME VAC
Agrovet
Segment by Type:
Attenuated Live Vaccines
Killed Vaccines
Segment by Application
Farm
Government
By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bovine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bovine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bovine Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Bovine Vaccines Product Introduction
1.2 Global Bovine Vaccines 麻豆原创 Size Forecast
1.2.1 Global Bovine Vaccines Sales Value (2019-2030)
1.2.2 Global Bovine Vaccines Sales Volume (2019-2030)
1.2.3 Global Bovine Vaccines Sales Price (2019-2030)
1.3 Bovine Vaccines 麻豆原创 Trends & Drivers
1.3.1 Bovine Vaccines Industry Trends
1.3.2 Bovine Vaccines 麻豆原创 Drivers & Opportunity
1.3.3 Bovine Vaccines 麻豆原创 Challenges
1.3.4 Bovine Vaccines 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bovine Vaccines Players Revenue Ranking (2023)
2.2 Global Bovine Vaccines Revenue by Company (2019-2024)
2.3 Global Bovine Vaccines Players Sales Volume Ranking (2023)
2.4 Global Bovine Vaccines Sales Volume by Company Players (2019-2024)
2.5 Global Bovine Vaccines Average Price by Company (2019-2024)
2.6 Key Manufacturers Bovine Vaccines Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Bovine Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Bovine Vaccines
2.9 Bovine Vaccines 麻豆原创 Competitive Analysis
2.9.1 Bovine Vaccines 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Bovine Vaccines Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bovine Vaccines as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Attenuated Live Vaccines
3.1.2 Killed Vaccines
3.2 Global Bovine Vaccines Sales Value by Type
3.2.1 Global Bovine Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Bovine Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Bovine Vaccines Sales Value, by Type (%) (2019-2030)
3.3 Global Bovine Vaccines Sales Volume by Type
3.3.1 Global Bovine Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Bovine Vaccines Sales Volume, by Type (2019-2030)
3.3.3 Global Bovine Vaccines Sales Volume, by Type (%) (2019-2030)
3.4 Global Bovine Vaccines Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Farm
4.1.2 Government
4.2 Global Bovine Vaccines Sales Value by Application
4.2.1 Global Bovine Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Bovine Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Bovine Vaccines Sales Value, by Application (%) (2019-2030)
4.3 Global Bovine Vaccines Sales Volume by Application
4.3.1 Global Bovine Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Bovine Vaccines Sales Volume, by Application (2019-2030)
4.3.3 Global Bovine Vaccines Sales Volume, by Application (%) (2019-2030)
4.4 Global Bovine Vaccines Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Bovine Vaccines Sales Value by Region
5.1.1 Global Bovine Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Bovine Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Bovine Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Bovine Vaccines Sales Value by Region (%), (2019-2030)
5.2 Global Bovine Vaccines Sales Volume by Region
5.2.1 Global Bovine Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Bovine Vaccines Sales Volume by Region (2019-2024)
5.2.3 Global Bovine Vaccines Sales Volume by Region (2025-2030)
5.2.4 Global Bovine Vaccines Sales Volume by Region (%), (2019-2030)
5.3 Global Bovine Vaccines Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Bovine Vaccines Sales Value, 2019-2030
5.4.2 North America Bovine Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Bovine Vaccines Sales Value, 2019-2030
5.5.2 Europe Bovine Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Bovine Vaccines Sales Value, 2019-2030
5.6.2 Asia Pacific Bovine Vaccines Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Bovine Vaccines Sales Value, 2019-2030
5.7.2 South America Bovine Vaccines Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bovine Vaccines Sales Value, 2019-2030
5.8.2 Middle East & Africa Bovine Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bovine Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Bovine Vaccines Sales Value
6.2.1 Key Countries/Regions Bovine Vaccines Sales Value, 2019-2030
6.2.2 Key Countries/Regions Bovine Vaccines Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Bovine Vaccines Sales Value, 2019-2030
6.3.2 United States Bovine Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Bovine Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bovine Vaccines Sales Value, 2019-2030
6.4.2 Europe Bovine Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Bovine Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Bovine Vaccines Sales Value, 2019-2030
6.5.2 China Bovine Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Bovine Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Bovine Vaccines Sales Value, 2019-2030
6.6.2 Japan Bovine Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Bovine Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Bovine Vaccines Sales Value, 2019-2030
6.7.2 South Korea Bovine Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Bovine Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Bovine Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Bovine Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Bovine Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Bovine Vaccines Sales Value, 2019-2030
6.9.2 India Bovine Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Bovine Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Jinyu Group
7.1.1 Jinyu Group Company Information
7.1.2 Jinyu Group Introduction and Business Overview
7.1.3 Jinyu Group Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Jinyu Group Bovine Vaccines Product Offerings
7.1.5 Jinyu Group Recent Development
7.2 Cavet Bio
7.2.1 Cavet Bio Company Information
7.2.2 Cavet Bio Introduction and Business Overview
7.2.3 Cavet Bio Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Cavet Bio Bovine Vaccines Product Offerings
7.2.5 Cavet Bio Recent Development
7.3 CAHIC
7.3.1 CAHIC Company Information
7.3.2 CAHIC Introduction and Business Overview
7.3.3 CAHIC Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.3.4 CAHIC Bovine Vaccines Product Offerings
7.3.5 CAHIC Recent Development
7.4 Tecon Group
7.4.1 Tecon Group Company Information
7.4.2 Tecon Group Introduction and Business Overview
7.4.3 Tecon Group Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Tecon Group Bovine Vaccines Product Offerings
7.4.5 Tecon Group Recent Development
7.5 Shen Lian
7.5.1 Shen Lian Company Information
7.5.2 Shen Lian Introduction and Business Overview
7.5.3 Shen Lian Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Shen Lian Bovine Vaccines Product Offerings
7.5.5 Shen Lian Recent Development
7.6 Biogenesis Bag贸
7.6.1 Biogenesis Bag贸 Company Information
7.6.2 Biogenesis Bag贸 Introduction and Business Overview
7.6.3 Biogenesis Bag贸 Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Biogenesis Bag贸 Bovine Vaccines Product Offerings
7.6.5 Biogenesis Bag贸 Recent Development
7.7 BIGVET Biotech
7.7.1 BIGVET Biotech Company Information
7.7.2 BIGVET Biotech Introduction and Business Overview
7.7.3 BIGVET Biotech Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.7.4 BIGVET Biotech Bovine Vaccines Product Offerings
7.7.5 BIGVET Biotech Recent Development
7.8 Indian Immunologicals
7.8.1 Indian Immunologicals Company Information
7.8.2 Indian Immunologicals Introduction and Business Overview
7.8.3 Indian Immunologicals Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Indian Immunologicals Bovine Vaccines Product Offerings
7.8.5 Indian Immunologicals Recent Development
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Company Information
7.9.2 Boehringer Ingelheim Introduction and Business Overview
7.9.3 Boehringer Ingelheim Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Boehringer Ingelheim Bovine Vaccines Product Offerings
7.9.5 Boehringer Ingelheim Recent Development
7.10 MSD Animal Health
7.10.1 MSD Animal Health Company Information
7.10.2 MSD Animal Health Introduction and Business Overview
7.10.3 MSD Animal Health Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.10.4 MSD Animal Health Bovine Vaccines Product Offerings
7.10.5 MSD Animal Health Recent Development
7.11 CEVA
7.11.1 CEVA Company Information
7.11.2 CEVA Introduction and Business Overview
7.11.3 CEVA Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.11.4 CEVA Bovine Vaccines Product Offerings
7.11.5 CEVA Recent Development
7.12 Bayer HealthCare
7.12.1 Bayer HealthCare Company Information
7.12.2 Bayer HealthCare Introduction and Business Overview
7.12.3 Bayer HealthCare Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Bayer HealthCare Bovine Vaccines Product Offerings
7.12.5 Bayer HealthCare Recent Development
7.13 VECOL
7.13.1 VECOL Company Information
7.13.2 VECOL Introduction and Business Overview
7.13.3 VECOL Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.13.4 VECOL Bovine Vaccines Product Offerings
7.13.5 VECOL Recent Development
7.14 Boehringer Ingelheim
7.14.1 Boehringer Ingelheim Company Information
7.14.2 Boehringer Ingelheim Introduction and Business Overview
7.14.3 Boehringer Ingelheim Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Boehringer Ingelheim Bovine Vaccines Product Offerings
7.14.5 Boehringer Ingelheim Recent Development
7.15 Brilliant Bio Pharma
7.15.1 Brilliant Bio Pharma Company Information
7.15.2 Brilliant Bio Pharma Introduction and Business Overview
7.15.3 Brilliant Bio Pharma Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Brilliant Bio Pharma Bovine Vaccines Product Offerings
7.15.5 Brilliant Bio Pharma Recent Development
7.16 VETAL
7.16.1 VETAL Company Information
7.16.2 VETAL Introduction and Business Overview
7.16.3 VETAL Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.16.4 VETAL Bovine Vaccines Product Offerings
7.16.5 VETAL Recent Development
7.17 BVI
7.17.1 BVI Company Information
7.17.2 BVI Introduction and Business Overview
7.17.3 BVI Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.17.4 BVI Bovine Vaccines Product Offerings
7.17.5 BVI Recent Development
7.18 LIMOR
7.18.1 LIMOR Company Information
7.18.2 LIMOR Introduction and Business Overview
7.18.3 LIMOR Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.18.4 LIMOR Bovine Vaccines Product Offerings
7.18.5 LIMOR Recent Development
7.19 ME VAC
7.19.1 ME VAC Company Information
7.19.2 ME VAC Introduction and Business Overview
7.19.3 ME VAC Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.19.4 ME VAC Bovine Vaccines Product Offerings
7.19.5 ME VAC Recent Development
7.20 Agrovet
7.20.1 Agrovet Company Information
7.20.2 Agrovet Introduction and Business Overview
7.20.3 Agrovet Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Agrovet Bovine Vaccines Product Offerings
7.20.5 Agrovet Recent Development
8 Industry Chain Analysis
8.1 Bovine Vaccines Industrial Chain
8.2 Bovine Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bovine Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Bovine Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Jinyu Group
Cavet Bio
CAHIC
Tecon Group
Shen Lian
Biogenesis Bag贸
BIGVET Biotech
Indian Immunologicals
Boehringer Ingelheim
MSD Animal Health
CEVA
Bayer HealthCare
VECOL
Boehringer Ingelheim
Brilliant Bio Pharma
VETAL
BVI
LIMOR
ME VAC
Agrovet

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.